Fty



Indications and Reactions:

Role Indications Reactions
Primary
Multiple Sclerosis 49.0%
Hypertension 8.3%
Relapsing-remitting Multiple Sclerosis 6.7%
Prophylaxis 6.6%
Depression 5.2%
Dyspepsia 3.8%
Muscle Spasms 3.3%
Thrombosis Prophylaxis 2.8%
Contraception 2.2%
Multiple Sclerosis Relapse 1.6%
Fatigue 1.4%
Sleep Disorder 1.4%
Trigeminal Neuralgia 1.4%
Muscle Spasticity 1.0%
Musculoskeletal Pain 1.0%
Pain 1.0%
Constipation 0.9%
Hypothyroidism 0.9%
Insomnia 0.9%
Nasopharyngitis 0.9%
Basal Cell Carcinoma 30.7%
Breast Cancer 9.3%
Myocardial Infarction 9.3%
Epilepsy 4.7%
Breast Dysplasia 4.0%
Bowen's Disease 3.3%
Bradycardia 3.3%
Decreased Appetite 3.3%
Electrocardiogram Qt Prolonged 3.3%
Skin Lesion 3.3%
Angina Pectoris 2.7%
Cerebral Haemorrhage 2.7%
Chest Pain 2.7%
Concomitant Disease Progression 2.7%
Hemianopia 2.7%
Metastatic Neoplasm 2.7%
Multiple Sclerosis Relapse 2.7%
Pulmonary Tuberculosis 2.7%
Bartholin's Abscess 2.0%
Breast Cancer In Situ 2.0%
Secondary
Multiple Sclerosis 33.7%
Prophylaxis 13.3%
Dyspepsia 12.7%
Thrombosis Prophylaxis 6.6%
Depression 4.7%
Hypertension 4.4%
Fatigue 3.3%
Gastritis Prophylaxis 3.3%
Local Anaesthesia 3.3%
Supplementation Therapy 3.3%
Relapsing-remitting Multiple Sclerosis 2.8%
Hypertonia 2.2%
Hypothyroidism 1.7%
Neuralgia 1.4%
Psoriasis 1.1%
Renal Transplant 0.8%
Pain 0.6%
Benign Prostatic Hyperplasia 0.3%
Muscle Spasticity 0.3%
Neurogenic Bladder 0.3%
Myocardial Infarction 8.8%
Skin Lesion 8.8%
Yellow Skin 8.8%
Basal Cell Carcinoma 7.4%
Breast Dysplasia 7.4%
Adnexa Uteri Mass 5.9%
Decreased Appetite 5.9%
Chest Pain 4.4%
Delusional Disorder, Persecutory Type 4.4%
Epigastric Discomfort 4.4%
Hepatitis E 4.4%
Skin Neoplasm Excision 4.4%
Stress 4.4%
Alanine Aminotransferase Increased 2.9%
Bowen's Disease 2.9%
Breast Cancer 2.9%
Breast Operation 2.9%
Bronchitis 2.9%
Cholelithiasis 2.9%
Constipation 2.9%